Multiple sclerosis patients using Biogen Idec (NASDAQ:BIIB) drug Tysabri now have access to the first test that can help determine their risk for developing a rare but potentially fatal brain infection that affects some patients using the drug.The U.S. Food and Drug Administration today cleared the blood test which can help doctors determine whether MS [...]

Clinical research organization inVentiv Health is strengthening its healthcare research and analytics offerings by acquiring two businesses from IMS Health under an agreement announced Tuesday.IMS is divesting the two business units as a condition of an acquisition of its own. IMS last January announced a deal to acquire SDI Health, aPennsylvania healthcare analytics firm. The [...]

A look at how Boston Scientific has shaped the emerging med tech landscape, and where the ex-BSC-ers are making their impact now.

Above Stress makes a healthcare mobile app that provides a straight forward way to outline an individual’s stress levels, and hopes their product will win over wellness programs, insurance companies and other organizations looking for ways to increase preventive care.

What’s the top life sciences market in the country? It’s Boston, according to a new study.In what’s sure to spark debate and friendly competition among the nation’s life science hubs, real estate and financial services firm Jones Lang LaSalle (NYSE:JLL) unveiled a report ranking the top life sciences clusters. Following Boston were New York/New Jersey, [...]

Biogen Idec (NASDAQ:BIIB) is on track to add a third multiple sclerosis therapy to its portfolio — one with blockbuster drug potential.The biotechnology company on Wednesday reported positive results from the second of two phase 3 trials on its MS drug candidate BG-12. In a two-year study, a twice daily dosage reduced the annualized relapse [...]

Cambridge, Massachusetts-based startup MC10‘s conformable electronics allow for stretchable and bendable new form factors for medical devices.In August, the company closed a nearly $15 million series B round of investment led by Braemar Energy Ventures, with participation from North Bridge Venture Partners, Osage University Partners, Windham Venture Partners and Terawatt Ventures.In an interview at the [...]

Johnson & Johnson’s (NYSE:JNJ) Michael Mahoney will begin leading Boston Scientific (NYSE:BSX) in October, first as president and then begin his tenure at CEO in November. Mahoney joins Boston Scientific at a challenging time, as the company struggles with limited growth in its heart device markets, which generate 70 percent of its total [...]

Shares of Boston Scientific Corp. (NYSE:BSX) traded at unusually high volumes for two straight weeks during the recent roller coast on Wall Street, coming in at more than 120 million trades during the week ending July 29 and topping 140 million the week ending August 5.Last week shaped up to top [...]

GI Dynamics officials are still on the down low about their IPO down under, but the company’s offering of more than 72 million shares of stock on the Australian exchange opened yesterday.The Lexington, Mass.-based device company is making available some 72.7 million chess depository interests at a price of A$1.10 per CDIs, [...]